… importance of Acinetobacter pittii and Acinetobacter nosocomialis has increased in the
nosocomial setting in the last decade, infections caused by Acinetobacter baumannii still have …

… Polymyxin B has been used as a therapeutic option lately: therefore, we need an
interpretative criterion. Disk diffusion cannot be used, as the inaccurate results obtained may be …

… baumannii, including biological and epidemiological aspects as well as resistance to
antibiotics and antibiotic therapy, are reviewed in this article, in addition to therapeutic …

… baumannii and peruse the tigecycline resistance mechanisms and novel therapeutic options.
Among the novel therapeutic strategies we focus on combination therapy, drug repurposing…

… the effectiveness of empirical therapy, and the availability of definitive therapeutic options.
A … of ineffective empirical antimicrobial therapy for Acinetobacter bacteremia was an …

… Treatment of severe infections due to drug-resistant Acinetobacter baumannii, a non-fermenting
Gram-negative coccobacillus, remains a challenge for clinicians [Citation1]. In particular, …

… This article reviews available information about the new drugs and other therapeutic options
focusing on agents in clinical or late-stage preclinical studies for the treatment of CRAB, and …

… , Acinetobacter infections were treatable with ampicillin, carbenicillin, gentamicin, and nalidixic
acid, either as a monotherapy or combination therapy, … of antimicrobial therapy against A. …

… In summary, our study provides valuable information for potential expansion of our current
therapeutic options against colistin-resistant A. baumannii infection with use of antibiotics that …

… Multidrug-resistant (MDR) strains of Acinetobacter baumannii are microorganisms that are
… serious infections with few viable therapeutic options. A. baumannii has the ability to survive …